These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 231297)

  • 1. Changes in the fecal flora of patients with Crohn's disease during treatment with metronidazole. A preliminary report.
    Krook A; Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1979; 14(6):705-10. PubMed ID: 231297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn's disease.
    Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1981; 16(2):183-92. PubMed ID: 6118940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora.
    Krook A; Järnerot G; Danielsson D
    Scand J Gastroenterol; 1981; 16(4):569-75. PubMed ID: 6119763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
    Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE
    J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of bacteroides species to metronidazole during treatment of patients with Crohn's disease and healthy individuals.
    Krook A; Kjellander J; Danielsson D
    Scand J Infect Dis; 1982; 14(1):45-8. PubMed ID: 7071526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
    Gosselink MP; Schouten WR; van Lieshout LM; Hop WC; Laman JD; Ruseler-van Embden JG
    Dis Colon Rectum; 2004 Sep; 47(9):1519-25. PubMed ID: 15486751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.
    Van de Merwe JP; Schröder AM; Wensinck F; Hazenberg MP
    Scand J Gastroenterol; 1988 Nov; 23(9):1125-31. PubMed ID: 3247591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The faecal flora of patients with Crohn's disease.
    Wensinck F; Custers-van Lieshout ; Poppelaars-Kustermans PA; Schröder AM
    J Hyg (Lond); 1981 Aug; 87(1):1-12. PubMed ID: 7019315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metronidazole and sulfasalazine on the normal human faecal flora.
    Krook A
    Scand J Gastroenterol; 1981; 16(5):587-92. PubMed ID: 6119764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
    Krook A; Lindström B; Kjellander J; Järnerot G; Bodin L
    J Clin Pathol; 1981 Jun; 34(6):645-50. PubMed ID: 7251906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study.
    Ambrose NS; Allan RN; Keighley MR; Burdon DW; Youngs D; Barnes P; Lennard-Jones JE
    Dis Colon Rectum; 1985 Feb; 28(2):81-5. PubMed ID: 3882364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Metronidazole in Crohn's disease.
    Cohen M
    Lancet; 1975 May; 1(7918):1236. PubMed ID: 48852
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects.
    Ruseler-van Embden JG; Both-Patoir HC
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):125-32. PubMed ID: 6614898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.
    Shiga H; Kajiura T; Shinozaki J; Takagi S; Kinouchi Y; Takahashi S; Negoro K; Endo K; Kakuta Y; Suzuki M; Shimosegawa T
    Dig Liver Dis; 2012 Sep; 44(9):736-42. PubMed ID: 22622202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C; Berto E; Scribano ML; Falasco G
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglutination of Eubacterium and Peptostreptococcus species as a diagnostic test for Crohn's disease.
    van de Merwe JP
    Hepatogastroenterology; 1981 Jun; 28(3):155-6. PubMed ID: 7250896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy.
    Dahlen G; Preus HR
    Anaerobe; 2017 Feb; 43():94-98. PubMed ID: 27988390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of Crohn's disease with metronidazole -- an uncontrolled trial --.
    Kasper H; Sommer H; Kühn HA
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):217-21. PubMed ID: 573534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease].
    Zhang T; Chen Y; Wang Z; Zhou Y; Zhang S; Wang P; Xie S; Jiang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1474-7. PubMed ID: 24144750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of metronidazole and its main metabolite in patients with active Crohn's disease: correlation with disease activity and therapeutic efficacy?
    Schneider MU; Riemann JF; Laudage G
    Chemotherapy; 1984; 30(6):345-52. PubMed ID: 6518833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.